Magalie Berthiaume
Overview
Explore the profile of Magalie Berthiaume including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berthiaume M, Laplante M, Festuccia W, Berger J, Thieringer R, Deshaies Y
Metabolism
. 2009 Sep;
59(1):114-7.
PMID: 19766266
This study aimed to explore in a model of diet-induced steatosis the impact of pharmacologic 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibition, under conditions of unchanged ingestive behavior, on liver fat...
2.
Festuccia W, Oztezcan S, Laplante M, Berthiaume M, Michel C, Dohgu S, et al.
Endocrinology
. 2008 Jan;
149(5):2121-30.
PMID: 18218698
Peroxisome proliferator-activated receptor-gamma (PPARgamma) activation up-regulates thermogenesis-related genes in rodent white and brown adipose tissues (WAT and BAT) without increasing whole-body energy expenditure. We tested here whether such dissociation is...
3.
Berthiaume M, Laplante M, Festuccia W, Cianflone K, Turcotte L, Joanisse D, et al.
Am J Physiol Endocrinol Metab
. 2007 Aug;
293(4):E1045-52.
PMID: 17666487
Tissue-specific alterations in 11beta-hydroxysteroid dehydrogenase (HSD) type 1 activity, which amplifies glucocorticoid action, are thought to contribute to some of the metabolic complications of obesity. The present study tested whether...
4.
Berthiaume M, Laplante M, Festuccia W, Gelinas Y, Poulin S, Lalonde J, et al.
Endocrinology
. 2007 Feb;
148(5):2391-7.
PMID: 17272400
The metabolic consequences of visceral obesity have been associated with amplification of glucocorticoid action by 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) in adipose tissue. This study aimed to assess in a...
5.
Berthiaume M, Sell H, Lalonde J, Gelinas Y, Tchernof A, Richard D, et al.
Am J Physiol Regul Integr Comp Physiol
. 2004 Jul;
287(5):R1116-23.
PMID: 15256367
Peroxisome proliferator-activated receptor gamma (PPARgamma) agonists improve insulin sensitivity and lipemia partly through enhancing adipose tissue proliferation and capacity for lipid retention. The agonists also reduce local adipose glucocorticoid production,...